Patent 7659265 was granted and assigned to Wyeth on February, 2010 by the United States Patent and Trademark Office.
Thioamide compounds, and specifically, thioamide pyrrole compounds, and preparation thereof are provided. These thioamide compounds can be used as progesterone receptor modulators, in contraception, and in the treatment of progesterone-related maladies.